Analyst Conference Summaries

Biotechnology Investor Aids

BioLineRx
BLRX

conference date: August 15, 2024 @ 5:30 AM Pacific Time

2024
BioLineRx
BLRX
Q1 2024
BioLineRx
BLRX
Q2 2024
   
May 28, 2024 Aug. 15, 2024    
2023
    BioLineRx
BLRX
Q3 2023
BioLineRx
BLRX
Q4 2023
    Nov. 20, 2023 Mar. 26, 2024

Biolinerx (BLRX) is a recently commercial stage biotechnology company specializing in therapies for stem cell mobilization to combine with cancer therapies.

Biolinerx web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALLO
 ALNY
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BMY
 BLUE
 CLDX
 CDTX
 GILD
 GLYC
 ILMN
 IMGN
 INCY
 INKT
 INO
 IONS
 MCHP
 MRNA
 PLX
 REGN
 RNA
 SAGE
 SANA
 SYRS
 TSVT
 VSTM
 VRTX
 WBA
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2024 William P. Meyers